Eighty percent of French sport winners in Olympic, World and Europeans competitions have mutations in the hemochromatosis HFE gene
Olivier Hermine(Centre National de la Recherche Scientifique), Jean‐François Toussaint(Université Paris Cité), F Van Lierde(Université de Technologie de Troyes), Laurie-Anne Marquet(Laboratoire Motricité Humaine Éducation Sport Santé), Muriel Tafflet(Inserm), G. Fumagalli(Université de Technologie de Troyes), Philippe Noirez(Délégation Paris 5), Jean-Claude Lapostolle(Fédération française de cardiologie), Flavia Guillem(Délégation Paris 5), Jean-Pierre Cervetti(Fédération française de cardiologie), Gérard Dine(Université de Technologie de Troyes), Christian Palierne(Institut National du Sport, de l'Expertise et de la Performance), Alain Frey(Fédération française de cardiologie), Marie‐Philippe Rousseaux‐Blanchi(Fédération française de cardiologie), Xavier Jouven(San Diego Cardiac Center), V. Genty(Université de Technologie de Troyes)
Cited by 38
Related Papers
Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival
|New England Journal of Medicine|2013|826
Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia
|JAMA Internal Medicine|2020|777
Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2017|736
Out-of-hospital cardiac arrest during the COVID-19 pandemic in Paris, France: a population-based, observational study
|The Lancet Public Health|2020|630
Improving health through policies that promote active travel: A review of evidence to support integrated health impact assessment
|Environment International|2011|620